Clinical Trial Update: Comparative Effectiveness of Two Acellular Matrices (Dermacell vs. Integra) for Management of Deep Diabetic Foot Ulcers [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing two acellular matrices (Dermacell vs. Integra) for deep diabetic foot ulcers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Diabetic Foot Ulcer
• Diabetic Foot Ulcer

Drugs mentioned

• DermACELL (acellular dermal matrix)
• Integra

Snippet

Sponsor: Baylor College of Medicine | Conditions: Diabetic Foot Ulcer, Deep Diabetic Foot Ulcer | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-07-07